Effects of seasons and light therapy on G protein levels in mononuclear leukocytes of patients with seasonal affective disorder

Archives of General Psychiatry

Volumn 56, Issue 2, 1999, Pages 178-183

  Avissar, Sofia ^a   Schreiber, Gabriel ^a   Nechamkin, Yakov ^a   Neuhaus, Isaac ^b   Lam, Gregory K ^b   Schwartz, Paul ^b   Turner, Erick ^b   Matthews, Jeffery ^b   Naim, Susana ^b   Rosenthal, Norman E ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSDUCIN;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DEPRESSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MONOCYTE; PHOTOTHERAPY; SUMMER; WINTER;

ADULT; BIOLOGICAL MARKERS; FEMALE; GTP-BINDING PROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHOTOTHERAPY; SEASONAL AFFECTIVE DISORDER; SEASONS; TRANSDUCIN; TREATMENT OUTCOME;

EID: 0033042796     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.56.2.178     Document Type: Article

References (45)

1. Rosenthal NE, Sack DA, Gillin JC, Lewy A J, Goodwin FK, Davenport Y, Mueller PS, Wehr TA. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41:72-80.
2. Rosenthal NE. Diagnosis and treatment of seasonal affective disorder. J Am Med Assoc. 1993;270:2717-2720.
3. Task Force Report of the American Psychiatric Association. Treatment of Psychiatric Disorders. Vol 3. Boston, Mass: APA Press; 1989;3:1890-1896.
4. Rosenthal NE. The Mechanism of Action of Light in the Treatment of Seasonal Affective Disorder (SAD) in Biologic Effects of Light. Berlin, Germany: Walter de Gruyter & Co; 1996:311-324.
5. Rudorfer MV, Skwerer RG, Rosenthal NE. Biogenic amines in seasonal affective disorder: effects of light therapy. Psychiatry Res. 1993;46:19-28.
6. Joseph-Vanderpool JR, Rosenthal NE, Chrousos G, Wehr TA, Kasper S, Gold PW. Abnormal pituitary-adrenal responses to CRH in patients with seasonal affective disorder: clinical and pathophysiological implications. J Clin Endocrinol Metab. 1991;72:1382-1387.
7. Gilman AG. G proteins: transducers of receptor-generated signals. Anna Rev Biochem. 1987;56:615-649.
8. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci. 1992;17:383-387.
9. Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 1988;331:440-442
10. Avissar S, Schreiber G. Muscarinic receptor subclassification and G proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics [Bennett Award Paper]. Biol Psychiatry. 1989;26:113-130.
11. Avissar S, Murphy DL, Schreiber G. Magnesium reverses lithium inhibition of beta adrenergic and muscarinic receptor coupling to G proteins. Biochem Pharmacol. 1991;41:171-175.
12. 5 protein function. Neuropharmacology. 1990;29:1067-1071.
13. Avissar S, Schreiber G, Aulakh CS, Murphy DL. Carbamazepine and electroconvulsive shock attenuate beta-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex. Eur J Pharmacol. 1990;100:99-103.
14. Avissar S, Schreiber G. The involvement of G proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry. 1992;31:435-459.
15. Avissar S, Schreiber G. Interaction of antibipolar and antidepressant treatments with receptor-coupled G proteins. Pharmacopsychiatry. 1992;25:44-50.
16. Meyniel G, Doly M, Gallard G. Electrophysiological demonstration of transducin inhibition by lithium. C R Acad Sci III. 1989;309:289-294.
17. Mork A, Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum and hippocampus from rats treated chronically with lithium. Biol Psychiatry. 1989;26:279-288.
18. Newman ME, Shapira B, Lerer B. Effects of lithium and desipramine on second messenger responses in rat hippocampus: relation to G protein effects. Neuropharmacology. 1991;30:1297-13101.
19. Manji HK, Bitran J, Masana M, Chen G, Hsiao JK, Risby ED, Rudorfer MW, Potter WZ. Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies. Psychopharmacol Bull. 1991;27:199-208
20. Song L, Jope RS. Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem. 1992;58:2200-2206.
21. 1-2 α subunit mRNA levels in rat cortex. Eur J Pharmacol. 1991;206:165-166.
22. 1α protein in rat brain. Eur J Pharmacol. 1991;207:355-359.
23. Schreiber G, Avissar S, Danon A, Belmaker RH. Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol Psychiatry. 1991;29:273-280.
24. Avissar S, Nechamkin Y, Roitman G, Schreiber G. Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. J Affect Disord. 1997;43:85-93.
25. Friedman E, Wang HY. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J Neurochem. 1996; 67:1145-1152.
26. 5α subunit levels are elevated in bipolar affective disorder. Brain Res. 1991;553: 323-326.
27. 5 protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neumchem. 1993;61:890-898.
28. 5α immunoreactivity in mononuclear leukocytes of patients with depression. Biol Psychiatry. 1996;39: 755-760.
29. Karege F, Bovier P, Stepanian R, Gaillard JM. Change in platelet GTP-binding protein in drug-free depressed patients. Hum Psychopharmacol. 1996;11:115-121.
30. Avissar S, Nechamkin Y, Roitman G, Schreiber G. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. Am J Psychiatry. 1997;154:211-217.
31. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry. 1994;151:594-596.
32. Barki-Harrington L, Nechamkin Y, Schreiber G, Avissar S. Functional and quantitative measures of receptor coupled G proteins in human mononuclear leukocytes: no change with age. Exp Gerontol. 1996;31:351-363.
33. Williams JBW, Link MJ, Rosenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Scale-Seasonal Affective Disorder Version. New York, NY: New York State Psychiatric Institute; 1988.
34. Terman JS, Terman M, Schlager D, Raffery B, Rosofsky AB, Link MJ, Gallin PF, Quitkin FM. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacol Bull. 1990;26:3-11.
35. Avissar S, Nechamkin Y, Roitman G, Schreiber G. Normalization dynamics by electroconvulsive treatment of reduced G protein levels and functions in mononuclear leukocytes of patients with major depression. Am J Psychiatry. 1998; 155:666-671.
36. Roszman TL, Brooks WH. Neural modulation of immune function. J Neuroimmunol. 1985;10:59-69.
37. Livnat S, Felten SY, Carlson SL, Bellinger DL, Felten DL. Involvement of peripheral and central catecholamine systems in neural immune interactions. J Neuroimmunol. 1985;10:5-30.
38. Fung BKK, Hurley JB, Stryer L. Row of information in the light-triggered cyclic nucleotide cascade of vision. Proc Natl Acad Sci USA. 1981;78:152-156.
39. Lam RW, Beattie CW, Buchanan A, Mador JA. Electroretinography in seasonal affective disorder. Psychiatry Res. 1992;43:55-63.
40. Oren DA, Moul DE, Schwartz PJ, Alexander JR, Yamada EM, Rosenthal NE. An investigation of ophthalmic function in winter seasonal affective disorder. Depression. 1993;1:29-37.
41. Lam RW, Beattie CW, Buchanan A, Remick RA, Zis AP. Low electrooculographic ratios in patients with seasonal affective disorder. Am J Psychiatry. 1991;148: 1526-1529.
42. Ozaki N, Rosenthal NE, Myers F, Schwartz PJ, Oren DA. Effects of season on electro-oculographic ratio in winter seasonal affective disorder. Psychiatry Res. 1995;59:151-155.
43. Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 1993;33:496-504.
44. Schwartz PJ, Murphy DL, Garcia-Borreguero D, Oren DA, Moul DE, Ozaki N, Snelbaker AJ, Wehr TA, Rosenthal NE. Effects of m-CPP infusions in patients with seasonal affective disorder and healthy controls: diurnal responses and nocturnal regulatory mechanisms. Arch Gen Psychiatry. In press.
45. Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JL, Murphy DL. Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Res. 1994;52:181-197.